Crossmark

Combined crizotinib and endocrine drugs inhibit proliferation, migration, and colony formation of breast cancer cells via downregulation of MET and estrogen receptor

Crossref DOI link: https://doi.org/10.1007/s12032-021-01458-1

Published Online: 2021-01-15

Published Print: 2021-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ayoub, Nehad M. https://orcid.org/0000-0002-6643-8553
Alkhalifa, Amer E.

Ibrahim, Dalia R.

Alhusban, Ahmed
Funding

Funding for this research was provided by:

Deanship of Research, Jordan University of Science and Technology (20180279)
License Information

Text and Data Mining valid from 2021-01-01

Version of Record valid from 2021-01-01
More Information

Article History

Received: 13 November 2020

Accepted: 1 January 2021

First Online: 15 January 2021

Compliance with ethical standards

:

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below